PHARM.NYC Trademark

Trademark Overview

On Tuesday, November 23, 2021, a trademark application was filed for PHARM.NYC with the United States Patent and Trademark Office. The USPTO has given the PHARM.NYC trademark a serial number of 97138742. The federal status of this trademark filing is ACTION CONTINUING FINAL - MAILED as of Wednesday, November 6, 2024. This trademark is owned by SeaBD LLC. The PHARM.NYC trademark is filed in the Pharmaceutical Products category with the following description:

Sports cream for relief of pain, none of the foregoing containing CBD solely derived from non-synthetically produced hemp extract with a delta9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
pharm.nyc

General Information

Serial Number97138742
Word MarkPHARM.NYC
Filing DateTuesday, November 23, 2021
Status649 - ACTION CONTINUING FINAL - MAILED
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSports cream for relief of pain, none of the foregoing containing CBD solely derived from non-synthetically produced hemp extract with a delta9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
Pseudo MarkPHARMACY NEW YORK CITY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 29, 2021
Primary Code005
First Use Anywhere DateThursday, July 1, 2021
First Use In Commerce DateSunday, August 1, 2021

Trademark Owner History

Party NameSeaBD LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressArverne, NY 11692

Trademark Events

Event DateEvent Description
Friday, November 26, 2021NEW APPLICATION ENTERED
Monday, November 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 5, 2022ASSIGNED TO EXAMINER
Thursday, September 22, 2022ASSIGNED TO EXAMINER
Thursday, April 6, 2023ASSIGNED TO EXAMINER
Thursday, April 13, 2023NON-FINAL ACTION WRITTEN
Thursday, April 13, 2023NON-FINAL ACTION E-MAILED
Thursday, April 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 16, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 16, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, August 17, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 26, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, October 26, 2023PETITION TO REVIVE-GRANTED
Thursday, October 26, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, October 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, March 13, 2024ASSIGNED TO LIE
Thursday, March 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 11, 2024FINAL REFUSAL WRITTEN
Thursday, April 11, 2024FINAL REFUSAL E-MAILED
Thursday, April 11, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, July 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 9, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 6, 2024NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Wednesday, November 6, 2024ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Wednesday, November 6, 2024ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

Related Keywords

pharm tetrahydrocannabinol delta extract hemp concentration more basis weight percent than